Lensar (LNSR) Free Cash Flow (QoQ) (2020 - 2026)
Lensar (LNSR) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -791.10% |
| Dec 31, 2025 | 117.59% |
| Sep 30, 2025 | 30.78% |
| Jun 30, 2025 | 26.92% |
| Mar 31, 2025 | -290.04% |
| Dec 31, 2024 | 16.63% |
| Sep 30, 2024 | 182.34% |
| Jun 30, 2024 | 29.71% |
| Mar 31, 2024 | -931.05% |
| Dec 31, 2023 | -53.96% |
| Sep 30, 2023 | 85.33% |
| Jun 30, 2023 | 65.32% |
| Mar 31, 2023 | -39.23% |
| Dec 31, 2022 | -2.38% |
| Sep 30, 2022 | -67.96% |
| Jun 30, 2022 | -5.54% |
| Mar 31, 2022 | -196.42% |
| Dec 31, 2021 | 61.02% |
| Sep 30, 2021 | -64.12% |
| Jun 30, 2021 | 70.44% |